Certificate of Conversion

Recorded: 2024-11-06 Pages: 9

Assignor

AROG PHARMACEUTICALS, LLC

Executed: 2014-09-30

Assignee

AROG PHARMACEUTICALS, INC.

2700 W. PLANO PKWY, PLANO, TEXAS, 75075

Covered Property (1)

Crenolanib for Treating FLT3 Mutated Proliferative Disorders

Application: 18/910,067 →

Publication: US 2025/0032475

Related Assignments (1)

Other recorded transfers of the patent in this record — the chain of ownership.